FR2909559B1 - Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation - Google Patents

Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation

Info

Publication number
FR2909559B1
FR2909559B1 FR0610638A FR0610638A FR2909559B1 FR 2909559 B1 FR2909559 B1 FR 2909559B1 FR 0610638 A FR0610638 A FR 0610638A FR 0610638 A FR0610638 A FR 0610638A FR 2909559 B1 FR2909559 B1 FR 2909559B1
Authority
FR
France
Prior art keywords
agent stimulating
cellular preparations
stimulating revascularization
revascularization
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0610638A
Other languages
English (en)
Other versions
FR2909559A1 (fr
Inventor
Gerard Tobelem
Ricousse Roussanne Sophie Le
Philippe Foubert
Jean Sebastien Silvestre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Universite Paris Diderot Paris 7
IVS Institut des Vaisseaux et du Sang
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Universite Paris Diderot Paris 7
IVS Institut des Vaisseaux et du Sang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0610638A priority Critical patent/FR2909559B1/fr
Application filed by Assistance Publique Hopitaux de Paris APHP, Universite Paris Diderot Paris 7, IVS Institut des Vaisseaux et du Sang filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to US12/517,281 priority patent/US20100086524A1/en
Priority to CA002670654A priority patent/CA2670654A1/fr
Priority to BRPI0719910-4A2A priority patent/BRPI0719910A2/pt
Priority to JP2009539782A priority patent/JP5390394B2/ja
Priority to PCT/FR2007/002003 priority patent/WO2008081116A2/fr
Priority to EP07871799A priority patent/EP2101795A2/fr
Priority to CN2007800509221A priority patent/CN101600446B/zh
Priority to AU2007341179A priority patent/AU2007341179B2/en
Publication of FR2909559A1 publication Critical patent/FR2909559A1/fr
Priority to IL199148A priority patent/IL199148A/en
Application granted granted Critical
Publication of FR2909559B1 publication Critical patent/FR2909559B1/fr
Priority to JP2013213256A priority patent/JP2014039560A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0610638A 2006-12-06 2006-12-06 Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation Expired - Fee Related FR2909559B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0610638A FR2909559B1 (fr) 2006-12-06 2006-12-06 Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
AU2007341179A AU2007341179B2 (en) 2006-12-06 2007-12-06 Cellular preparations for use as a revascularisation stimulating agent
BRPI0719910-4A2A BRPI0719910A2 (pt) 2006-12-06 2007-12-06 Preparação celular e utilização da mesma
JP2009539782A JP5390394B2 (ja) 2006-12-06 2007-12-06 血管再生促進薬剤
PCT/FR2007/002003 WO2008081116A2 (fr) 2006-12-06 2007-12-06 Préparations cellulaires pour une utilisation comme agent stimulant la revascularisation
EP07871799A EP2101795A2 (fr) 2006-12-06 2007-12-06 Préparations cellulaires pour une utilisation comme agent stimulant la revascularisation
US12/517,281 US20100086524A1 (en) 2006-12-06 2007-12-06 Cellular preparations for use as a revascularization stimulating agent
CA002670654A CA2670654A1 (fr) 2006-12-06 2007-12-06 Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
CN2007800509221A CN101600446B (zh) 2006-12-06 2007-12-06 用作血管再形成刺激剂的细胞制备物
IL199148A IL199148A (en) 2006-12-06 2009-06-04 Intracellular preparation for use as a stimulant for blood vessel development
JP2013213256A JP2014039560A (ja) 2006-12-06 2013-10-10 脈管形成組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0610638A FR2909559B1 (fr) 2006-12-06 2006-12-06 Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation

Publications (2)

Publication Number Publication Date
FR2909559A1 FR2909559A1 (fr) 2008-06-13
FR2909559B1 true FR2909559B1 (fr) 2012-09-07

Family

ID=38171140

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0610638A Expired - Fee Related FR2909559B1 (fr) 2006-12-06 2006-12-06 Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation

Country Status (10)

Country Link
US (1) US20100086524A1 (fr)
EP (1) EP2101795A2 (fr)
JP (2) JP5390394B2 (fr)
CN (1) CN101600446B (fr)
AU (1) AU2007341179B2 (fr)
BR (1) BRPI0719910A2 (fr)
CA (1) CA2670654A1 (fr)
FR (1) FR2909559B1 (fr)
IL (1) IL199148A (fr)
WO (1) WO2008081116A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
FR2957799B1 (fr) 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
JPWO2012096257A1 (ja) * 2011-01-12 2014-06-09 株式会社ライフアートビレッジ 育毛剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
FR2810045B1 (fr) * 2000-06-07 2004-09-03 Assist Publ Hopitaux De Paris Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
CA2461121A1 (fr) * 2001-09-20 2003-04-03 Kyowa Hakko Kogyo Co., Ltd. Cellules souches multipotentes dans les tissus interstiels des muscles squelettiques
US7354763B2 (en) * 2002-04-16 2008-04-08 Technion Research & Development Foundation Ltd. Generating vascular smooth muscle cells in vitro from ES cells
US7247477B2 (en) * 2002-04-16 2007-07-24 Technion Research & Development Foundation Ltd. Methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
FR2889200B1 (fr) * 2005-07-27 2008-01-04 Inst Vaisseaux Et Du Sang Ass Systeme marqueur cellulaire/ligand, ou le marqueur est du type eph, materiau cellulaire comprenant ce systeme, procede de preparation et utilisation proangiogenique
FR2890977A1 (fr) * 2005-09-19 2007-03-23 Assist Publ Hopitaux De Paris Procede d'obtention de cellules musculaires lisses humaines et leurs applications
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation

Also Published As

Publication number Publication date
US20100086524A1 (en) 2010-04-08
AU2007341179B2 (en) 2013-07-18
CA2670654A1 (fr) 2008-07-10
WO2008081116A2 (fr) 2008-07-10
JP5390394B2 (ja) 2014-01-15
AU2007341179A1 (en) 2008-07-10
BRPI0719910A2 (pt) 2014-03-04
WO2008081116A3 (fr) 2008-09-12
JP2014039560A (ja) 2014-03-06
CN101600446B (zh) 2013-04-24
JP2010511399A (ja) 2010-04-15
CN101600446A (zh) 2009-12-09
IL199148A (en) 2014-07-31
FR2909559A1 (fr) 2008-06-13
EP2101795A2 (fr) 2009-09-23

Similar Documents

Publication Publication Date Title
EP1876186A4 (fr) Agent prophylactique/thérapeutique pour le cancer
DE502004011788D1 (de) Fahrzeugkran
ATE517883T1 (de) Imidazolderivate als funktionelle selektive agonisten des alpha2c-adrenorezeptors
BRPI0812215A2 (pt) Descoberta de agente de origem de ip móvel
EP2067791A4 (fr) Agent prophylactique ou thérapeutique pour le cancer
DE602005003770D1 (de) Kolbenpumpe
EP2074571A4 (fr) Monétisation mobile
PT1735252E (pt) Aglutinante hidráulico
DE602005018980D1 (de) Rotationspumpe
FR2888505B1 (fr) Nouvelles compositions cosmetiques amincissantes
NL1030324A1 (nl) Sulfonylbenzimidazoolderivaten.
DE602005001074D1 (de) Wässerige Beschichtungszusammensetzung
BRPI0719514A2 (pt) Preparações líquidas aquosas compreendendo gatifloxacina
DK1978981T3 (da) Præparater til vaginal anvendelse
EP1857013A4 (fr) Applicateur pour le nail art
EP1949895A4 (fr) Preparation pour iontophorese
DE602006013094D1 (de) Krebsmittel
EP2111484A4 (fr) Agent de brillance polyamine
EP2018873A4 (fr) Agent prophylactique/therapeutique pour le cancer
FI20041057L (fi) Pelkistysainekoostumus
EP1923072A4 (fr) Agent prophylactique/thérapeutique pour le cancer
FR2941864B1 (fr) Substance active pour la protection de fgf-2
ITMI20040162A1 (it) Uso di polliaaminometilenfosfonati quali agenti disperdenti
EP1852499A4 (fr) Agent favorisant la neurotisation
FR2909559B1 (fr) Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20210806